Author:
Lee Sau L.,Yu Lawrence X.,Cai Bing,Johnsons Gibbes R.,Rosenberg Amy S.,Cherney Barry W.,Guo Wei,Raw Andre S.
Publisher
Springer Science and Business Media LLC
Reference55 articles.
1. Sexton PM, Findlay DM, Martin TJ. Calcitonin. Curr Med Chem. 1999;6:1067–93.
2. Sato M, Grese TA, Dodge JA, Byrant HU, Turner CH. Emerging therapies for the prevention or treatment of postmenopausal osteoporosis. J Med Chem. 1999;42:1–24.
3. Friedman PA. Agents affecting mineral ion homeostasis and bone turnover. In: Brunton LL, Lazo JS, Parker KL, editors. Goodman and gilman’s the pharmacological basis of therapeutics. 11th ed. New York: McGraw-Hill; 2005. pp. 1647–78.
4. Arvinte T, Cudd A, Drake AF. The structure and mechanism of formation of human calcitonin fibrils. J Biol Chem. 1993;268:6415–22.
5. Orange book: approved drug products with therapeutic equivalence evaluations. Available at: http://www.accessdata.fda.gov/scripts/cder/ob/default.cfm (2009). Accessed 4 January 2010
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献